SKI Market

A+| A| A-|

Indian Indices

Sensex

77,562.90 2,946.32
( 3.95%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

56,345.93 2,916.37
(5.46%)

Nikkei 225

10,596.41 247.62
(2.39%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524804

INE406A01037

369.1611632

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AUROPHARMA

36.02

77223.38

EPS(TTM)

Face Value()

Div & Yield %

36.91

Back

Sylph Industries reports standalone net profit of Rs 0.16 crore in the December 2025 quarter

Feb 13,2026

Net profit of Sylph Industries reported to Rs 0.16 crore in the quarter ended December 2025 as against net loss of Rs 1.72 crore during the previous quarter ended December 2024. Sales rose 982.52% to Rs 11.15 crore in the quarter ended December 2025 as against Rs 1.03 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	11.15	1.03	983
OPM %	-1.70	-166.99	-
PBDT	0.16	-1.72	LP
PBT	0.16	-1.72	LP
NP	0.16	-1.72	LP

77,562.90 2,946.32 ( 3.95%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

56,345.93 2,916.37 (5.46%)

10,596.41 247.62 (2.39%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)